Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y5OY
|
|||
| Former ID |
DIB010547
|
|||
| Drug Name |
MK-3641
|
|||
| Synonyms |
ALK Ragweed Tablet; Ragweed AIT; SCH-039641; SCH-39641; Ragweed allergy desensitization tablet, ALK-Abello; Amb-a-1-U; Allergy immunotherapy tablet (ragweed allergies), Merck & Co/ALK Abello; Biological ragweed allergen (sublingual, Zydis), ALK-Abello; Ragweed allergy desensitization tablet, ALK-Abello/Schering-Plough; AIT (ragweedallergy), Schering-Plough/ALK-Abello; Allergy immunotherapy tablet (ragweed allergies), Schering-Plough/ALK-Abello; Biological ragweed allergen (sublingual, Zydis), ALK-Abello/Schering-Plough
Click to Show/Hide
|
|||
| Indication | Allergy [ICD-11: 4A80-4A85; ICD-10: T78.4; ICD-9: 995.3] | Approved | [1], [2] | |
| Company |
ALK-Abello; merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Merck. | |||
| REF 2 | ClinicalTrials.gov (NCT02256553) Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (MK-3641-006). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.